Acquired Company

Sumitovant Biopharma completed the acquisition of Urovant Sciences on 3/29/2021, acquiring all outstanding shares and making Urovant a wholly owned subsidiary.

Show more

Medicinal and Botanical Manufacturing

Manufacturing

Start AI Chat

Market Cap

1.018B

52 Wk Range

$N/A - $N/A

Previous Close

$16.24

Open

$16.24

Volume

N/A

Day Range

$16.24 - $16.24

Enterprise Value

0.00

Cash

159.3M

Avg Qtr Burn

N/A

Insider Ownership

0.00%

Institutional Own.

0.00%

Qtr Updated

03/31/25

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date